$866M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | GHRS Gh Research Plc | 13.3M | +23.2% | $357M | 41.2% |
| 2 | CGEM Cullinan Therapeutics Inc | 9.0M | +0.0% | $163M | 18.9% |
| 3 | STOK Stoke Therapeutics Inc | 4.0M | −15.2% | $132M | 15.3% |
| 4 | AGIO Agios Pharmaceuticals Inc | 3.4M | +30.5% | $127M | 14.6% |
| 5 | CCCC C4 Therapeutics Inc | 7.3M | +4.7% | $34M | 4.0% |
| 6 | KRRO Korro Bio Inc | 1.5M | +0.0% | $20M | 2.3% |
| 7 | TCRX Tscan Therapeutics Inc | 8.0M | +0.0% | $8M | 0.9% |
| 8 | DTIL Precision Biosciences Inc | 950,466 | −3.5% | $7M | 0.9% |
| 9 | NEUP Neuphoria Therapeutics Inc | 875,328 | +0.0% | $4M | 0.4% |
| 10 | PASG Passage Bio Inc | 673,759 | +8.0% | $3M | 0.4% |
| 11 | CGON Cg Oncology Inc | 31,391 | −0.6% | $2M | 0.3% |
| 12 | PLRX Pliant Therapeutics Inc | 1.8M | — | $2M | 0.2% |
| 13 | TRDA Entrada Therapeutics Inc | 178,606 | −15.6% | $1M | 0.2% |
| 14 | VYNE THERAPEUTICS INC Vyne Therapeutics Inc | 1.6M | +0.0% | $1M | 0.1% |
| 15 | PROQR THRAPEUTICS N V Proqr Thrapeutics N V | 521,413 | +661.3% | $969,828 | 0.1% |
| 16 | TRAW Traws Pharma Inc | 559,470 | +3610.5% | $471,801 | 0.1% |
| 17 | FHTX Foghorn Therapeutics Inc | 61,588 | — | $300,549 | 0.0% |
| 18 | DNLI Denali Therapeutics Inc | 11,658 | −99.4% | $299,844 | 0.0% |
| 19 | XNCR Xencor Inc | 18,194 | −96.6% | $292,923 | 0.0% |
| 20 | ABSI Absci Corporation | 21,245 | +0.0% | $246,230 | 0.0% |
| 21 | HOWL Werewolf Therapeutics Inc | 657,786 | +0.0% | $236,737 | 0.0% |
| 22 | IMTX Immatics N.V | 23,236 | −89.3% | $235,381 | 0.0% |
| 23 | AVTX Avalo Therapeutics Inc | 10,100 | — | $186,648 | 0.0% |
| 24 | BOLT Bolt Biotherapeutics Inc | 30,800 | +0.0% | $118,580 | 0.0% |
| 25 | NUVB Nuvation Bio Inc | 16,029 | — | $91,045 | 0.0% |
| 26 | EPRX Eupraxia Pharmaceuticals Inc | 10,000 | — | $66,100 | 0.0% |
| 27 | IKT Inhibikase Therapeutics Inc | 20,000 | — | $40,600 | 0.0% |